Why aren't we using beta blockers after acute MI?

American Family Physician

Volumn 62, Issue 8, 2000, Pages 1771-1772

  Weichel, Amy S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL PRACTICE; MORTALITY; PRACTICE GUIDELINE;

ADRENERGIC BETA-ANTAGONISTS; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; HUMANS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 0034667844     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Optimizing beta-blocker utilization after acute myocardial infarction
2. The betablocker heart attack trial
3. Effect of betablockade on mortality among high-risk and low-risk patients after myocardial infarction
4. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings
5. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice